Pharmacovigilance in Public Health Programmes
Many Public Health Programmes (PHPs) involve the direct administration of medicines to large populations and communities for the prophylaxis, treatment and/or eradication of diseases. The large number of patients who will receive the drugs in a systematic manner in these programmes generates the possibility of harm if unmonitored and, at the same time, an opportunity to develop systems for generating valid and valuable data that will assist in decision making. PHPs and Pharmacovigilance (PV) can derive mutual benefits from each other; PV and adverse drug reactions monitoring in PHPs can detect rare adverse events and risk factors in patients and can have a tremendous positive impact on the implementation and success of these programmes; PHPs on the other hand can provide an opportunity to introduce PV in countries that lack a system for drug safety monitoring. Safety issues that are specific to various disease-control programmes (Chagas, HIV/AIDS, Malaria, Tuberculosis, etc) are being addressed through different Projects.
- A practical handbook on the pharmacovigilance of medicines used in the treatment of tuberculosis
- A practical handbook on the pharmacovigilance of antimalarial medicines
A practical handbook on the pharmacovigilance of antiretroviral medicines
The Safety of Medicines in Public Health Programmes
Technical Guidance Note for Global Fund HIV Proposals